Navigation Links
Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
Date:11/11/2008

CAMBRIDGE, England, November 11 /PRNewswire-FirstCall/ --

- ("Stem Cell Sciences", "SCS", "the Company")

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, announces that it has licensed IRES technology to a leading provider of genetically modified rat and mouse models for medical and pharmaceutical research. Under the terms of the multi-year agreement, which is non-exclusive and retroactive, the undisclosed partner will gain access to the IRES technology for use in its own research and development activities. Under the terms of the licence, SCS will receive US$750,000 over six years plus royalties.

SCS' IRES (Internal Ribosome Entry Site) technology enables researchers to monitor the activity of a particular gene of interest in living cells or tissues without blocking the normal function of the gene. In particular, IRES is important for evaluating the success of gene knock-outs or knock-ins in stem cells, which is crucial for the successful creation of transgenic mouse and rat disease models.

Dr Alastair Riddell, CEO of SCS, said "A key element of our commercial strategy is to realise both immediate and longer-term value from our extensive IP portfolio in the stem cell field through licence agreements such as this. We are therefore very pleased to have signed this agreement with one of the leading providers of transgenic animal models to the pharmaceutical research industry. We are continuing discussions with other companies, which may benefit from the use of SCS technology in conjunction with their own, and are optimistic of signing further agreements in the coming months."

About Stem Cell Sciences plc

Stem Cell Sciences (SCS) is an international research and development company focusing on the commercial application of stem cell biology technologies for drug discovery and regenerative medicine research. Stem Cell Sciences is now focussing
'/>"/>

SOURCE Stem Cell Sciences plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Palatin Technologies, In.... Patent and Trademark Office has issued U.S. Pate...de Constructs." The claims in the issued patent c...riuretic peptide receptor A (NPRA), including PL-3...,, "Our natriuretic compounds, including PL-399...
(Date:12/1/2009)... VANCOUVER, British Columbia, Dec. 1 /PRNewswire-F...subsidiary of The Dow Chemical Company (NYSE: DO...d the signing of a research and commercial license...Sciences with access to Agrisoma,s proprietary Eng...e basis in major food crops, and on a non-exclusiv...
(Date:12/1/2009)...ec. 1 /PRNewswire-FirstCall/ - BioSpec Global Solu...announced today that the company has contracted wi...for the manufacturing of the TOG,S 3000 and 9000(T...e have seen the disastrous results of food contami...salads in the past" said Don Saunders President an...
(Date:12/1/2009)...nical study presented to the American Society for ... (3-D) automated ultrasound follicle measurement u...ilization (IVF) cycle is effective and more effici...licles. , Gurnee, IL (PRW...ter of Chicago has just completed research on a ne...
Breaking Biology Technology:Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3
...a first-cycle,approval for a new molecular entity ...ental revenue on average, according to a new analy...REXEL International (Nasdaq: PRXL ),and leading g...rmaceutical,and medical device industries. Accordi...of sales for newly-approved drugs and biologics ea...
...ture of how the world communicates, and how we pow...e: nanotechnology. According to a just-released po...ging Nanotechnologies (PEN), nanotechnology will b... cheaper" electronics and "green" energy technolog...eries Trips to the Nanofrontier, journalist Karen ...
...tional Institute of Standards and Technology (NIST...ersity of Colorado (CU) at Boulder, have made the ...y reducing the uncertainty in delicate measurement...ost the speed and precision of quantum computing a...ers add unwanted noise, or random fluctuations, wh...
Other Biology Technology:PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 2PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 3PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 4PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 5First tunable, 'noiseless' amplifier may boost quantum computing, communications 2
(Date:11/30/2009)...rst comprehensive review of the state of Antarctic...mate system is published this week (Tuesday 1 Dece...earch (SCAR). The review - Antarctic Climate Chan...ch from the icy continent, identifies areas for fu... questions that policy makers have about Antarctic...
(Date:11/30/2009)... of scientists from The Forsyth Institute, the Uni...the Wadsworth Center, have used state-of-the-art t...of Treponema pallidum, the bacterium which causes ...e of the bacteria can now be shown in three dimens...thogen and reveals previously unknown features, wh...
(Date:11/30/2009)...leans, LA Researchers from LSU Health Sciences Ce...ennedy Shriver National Institute of Child Health ...ublic Health, Brigham and Women,s Hospital, and Ha...e that drinking more than 5 servings of sugar- swe...ignificantly elevate the risk of developing diabet...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3Swine Flu Virus Dominant Strain Worldwide 3A WHO 60774 1Swine Flu Virus Dominant Strain Worldwide 3A WHO 60774 2Swine Flu Virus Dominant Strain Worldwide 3A WHO 60774 3Practical Nursing Still a Growth Area in BC 60772 1Practical Nursing Still a Growth Area in BC 60772 2Sen Grassley Raised More Than 24150 000 Over the Summer From Health Care and Insurance Interests 60770 1Sen Grassley Raised More Than 24150 000 Over the Summer From Health Care and Insurance Interests 60770 2
...es, Iowa December 11, 2008 Throughout history, h...rom hailing a cab to carrying a tune. Now, an oran...sts at Great Ape Trust of Iowa new insights into t...published this month in Primates , an internation... all aspects of primates in relation to humans and...
...is Bolduc keeps more than 300,000 fruit flies in a...enes and then tests their mental abilities. He,s c... book villain, but Bolduc is no mad scientist. , ...lty of Medicine & Dentistry, Bolduc has shown that...1 in a fruit fly,s brain will wipe out its long-te...
...atellite studies could lead to a radical re-thinki...ecosystem. , "Six of the adult females that we f...nter far out on the Arctic sea ice," said Universi...ho is working with Professor Gilles Gauthier as pa...roject to better understand key indicator species ...
Other Biology News:Orangutan's spontaneous whistling opens new chapter in study of evolution of speech 2Orangutan's spontaneous whistling opens new chapter in study of evolution of speech 3'Fly guy' makes memory breakthrough 2Snowy owl -- a marine species? 2
Mouse Anti-Human Vasopressin Monoclonal Antibody, Unconjugated, Clone VAS 2-10-8 from Meridian Life Science, Inc.
Mouse Anti-PCTAIRE 2 Monoclonal Antibody, Unconjugated, Clone 0.N.509 from Abcam
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
...ary high-performance desalting resin, exclusive to...tein-recovery characteristics compared to other co... low as 25 g/ml of protein can be processed, provi...ion of salts and other small molecules ( Exceptio...
Biology Products: